Natera

Natera Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health.

Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 250 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas, and San Carlos, California.

12/18/2025

Dr. James Duke, a retired orthopedic surgeon, took charge of his cancer journey by requesting immunotherapy before surgery and integrating Signatera™ MRD testing into his care.

The result? A less invasive surgery, preserved quality of life, and 18 months recurrence-free. His story is a powerful reminder that informed patients can shape their outcomes.

Learn more: https://ow.ly/LFbF50XJOqg

12/01/2025

Kyle shares his experience with stage IV colon cancer and the role of early detection and personalized care. With the help of Signatera™ MRD testing, Kyle’s care team identified recurrence before imaging could and took swift action.

A heartfelt thank you to our amazing Natera employees who gave back during Volunteer Month! 💙Together, we contributed 1,...
11/26/2025

A heartfelt thank you to our amazing Natera employees who gave back during Volunteer Month! 💙

Together, we contributed 1,500+ volunteer hours across the U.S., supporting various organizations including food banks, cancer advocacy groups and animal shelters.

Since 2021, Naterans have volunteered 28,500+ hours, an incredible commitment to important causes close to our hearts.

We are so grateful for the generosity of our teams and their work to change the world!

“Signatera empowers me to be my own best advocate with my oncologists - it’s given me peace of mind.” — JoAnn, lung canc...
11/25/2025

“Signatera empowers me to be my own best advocate with my oncologists - it’s given me peace of mind.” — JoAnn, lung cancer survivor.

Signatera™ helps lung cancer survivors like JoAnn stay ahead of recurrence and track treatment response with confidence.

Hear JoAnn’s story: https://ow.ly/Y5kl50XwY7p

11/24/2025

After your transplant: Dr. Leca, Medical Director, Kidney and Pancreas Transplant Program Professor of Medicine/Nephrology at UW Medicine explains a key finding from the PEDAL study findings.

Learn more about how Prospera™ can be used for rejection monitoring in your post-transplant journey: https://ow.ly/FQ9450XtyKe

Even after decades in medicine, nothing can prepare you to hear the words, “you have cancer.” When Dr. James Duke, a ret...
11/14/2025

Even after decades in medicine, nothing can prepare you to hear the words, “you have cancer.”

When Dr. James Duke, a retired orthopedic surgeon, faced that diagnosis, he turned to what he knew best: science, innovation and teamwork. With support from his care team, he chose to pursue immunotherapy before surgery and added Signatera™ MRD testing to guide his treatment.

The result? A less invasive surgery, preserved quality of life and 18 months recurrence-free. His story is a powerful reminder that informed patients can shape their outcomes.

See Dr. Duke's full story here: https://ow.ly/Vtjo50XrZnk

11/13/2025

You've got your Renasight™ results, to learn about your kidney health. What's next? Our genetic counselors are here to help understand results and so much more. Learn more: https://ow.ly/RTTN50X9mV9

Join the upcoming webinar: Building the Evidence for ctDNA as a Surrogate Endpoint in Oncology Drug Development.November...
11/03/2025

Join the upcoming webinar: Building the Evidence for ctDNA as a Surrogate Endpoint in Oncology Drug Development.

November 19, 2025
9 AM PT | 12 PM ET | 5 PM GMT

Hear from experts as they discuss:
• Insights from recent studies evaluating ctDNA quantitation as an indicator of therapeutic response
• Practical applications of ctDNA for internal decision-making and dose optimization
• Collaborative approaches to expand multi-tumor data generation and strengthen the evidence base for endpoint qualification

Learn how response monitoring with ctDNA could accelerate the evaluation of therapy efficacy and clinical development.

Register today: https://ow.ly/HQRZ50Xm66w

Naterans assembled Kynd Kits through Project Helping to benefit First Descents, a non-profit that provides life-changing...
10/31/2025

Naterans assembled Kynd Kits through Project Helping to benefit First Descents, a non-profit that provides life-changing outdoor adventures for young adults impacted by cancer and other serious health conditions.

We're reflecting on how meaningful it was to support the Susan G. Komen More Than Pink Walk series during Breast Cancer...
10/31/2025

We're reflecting on how meaningful it was to support the Susan G. Komen More Than Pink Walk series during Breast Cancer Awareness Month. was honored to attend and volunteer at events across the country. The strength of the breast cancer community and survivors, including many Naterans, is incredible. Thank you, Susan G. Komen, for letting us be part of such an inspiring mission .

Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer earlier this month, an organization ...
10/25/2025

Proud to support the 4th Annual Gathering of the Wolves, hosted by Man Up To Cancer earlier this month, an organization dedicated to supporting men with any kind of cancer diagnosis, providing community and resources to guide them through treatment and beyond.

Natera is honored to stand beside the breast cancer community as a national sponsor of the Susan G. Komen More Than Pink...
10/21/2025

Natera is honored to stand beside the breast cancer community as a national sponsor of the Susan G. Komen More Than Pink Walk series. Together, we walk for hope, progress and a future without breast cancer. Thank you, Susan G. Komen, for welcoming us into this incredible community. 💗

Address

Belmont, CA

Website

Alerts

Be the first to know and let us send you an email when Natera posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Natera:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category